Structural and functional characterization of the poliovirus replication complex.
Two populations of membrane-bound replication complexes were isolated from poliovirus-infected HEp-2 cells by sucrose gradient centrifugation. The two fractions show similar ultrastructural features: the replication complex is enclosed in a rosettelike shell of virus-induced vesicles and contains a very tightly packed second membrane system (compact membranes). The vesicular fraction, which bands in 30% sucrose, contains replicative intermediate (RI) and 36S RNA. The fraction banding in 45% sucrose contains only minute amounts of RI and contains mainly 36S RNA, two-thirds of which is encapsidated. In vitro, the two fractions show similar RNA synthesizing capacities and produce 36S plus-strand RNA. Dissolving the membranes within and around synthetically active replication complexes with sodium deoxycholate abolishes the completion of 36S RNA but still allows elongation in the RI. Our findings suggest an architecture of the replication complex that has the nascent plus strands on the RI enclosed in the compact membranes and the replication forks wrapped additionally in protein. Plus-strand RNA can be localized by in situ hybridization with a biotinylated riboprobe between the replication complex and the rosette of the virus-induced vesicles. It was found that the progeny RNA strands are set free soon after completion from the replication complex at the sites where the compact membranes within the replication complex are in close contact with the surrounding virus-induced vesicles.
Bienz
K
K
Institute for Medical Microbiology, University of Basel, Switzerland.
Egger
D
D
Pfister
T
T
Troxler
M
M
D002478:Cells, Cultured; D002499:Centrifugation, Density Gradient; D003840:Deoxycholic Acid / Q000494:pharmacology; D006801:Humans; D007150:Immunohistochemistry; D046911:Macromolecular Substances; D009693:Nucleic Acid Hybridization; D011051:Poliomyelitis / Q000378:metabolism; D017955:Poliovirus / Q000254:growth & development* / Q000302:isolation & purification / Q000648:ultrastructure; D012367:RNA, Viral / Q000302:isolation & purification* / Q000378:metabolism / Q000648:ultrastructure; D013347:Subcellular Fractions / Q000737:chemistry / Q000187:drug effects / Q000648:ultrastructure; D014158:Transcription, Genetic; D014764:Viral Proteins / Q000302:isolation & purification* / Q000378:metabolism / Q000648:ultrastructure; D014779:Virus Replication
D046911:Macromolecular Substances; D012367:RNA, Viral; D014764:Viral Proteins; D003840:Deoxycholic Acid